Effect of thimerosal, methylmercury, and mercuric chloride in Jurkat T cell line

Interdisciplinary Toxicology

Volumn 5, Issue 3, 2012, Pages 159-161

  Guzzi, Gianpaolo ^a   Pigatto, Paolo D ^b   Spadari, Francesco ^b   La Porta, Caterina A M ^b  

^a Italian Association for Metals and Biocompatibility Research AIRMEB   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Cell death drug effects; Cell survival drug effects; Mitochondrial membranes drug effects; MTT; Organic mercury compounds; T lymphocytes drug effects

Indexed keywords

MERCURIC CHLORIDE; METHYLMERCURY; THIOMERSAL;

ARTICLE; CELL DEATH; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE;

EID: 84876548456     PISSN: 13376853     EISSN: 13379569     Source Type: Journal    
DOI: 10.2478/v10102-012-0026-1     Document Type: Article

References (26)

1. Aleo MF, Morandini F, Bettoni F, Tanganelli S, Vezzola A, Giuliani R, et al. (2002). In vitro study of the nephrotoxic mechanism of mercuric chloride. Med Lav 93:267-278. (Pubitemid 36267825)
2. Clarkson TW. (1997) The toxicology of mercury. Crit Rev Clin Lab Sci 34:369-403. (Pubitemid 27448331)
3. Shenker BJ, Rooney C, Vitale L, Shapiro IM. (1992) Immunotoxic effects of mercuric compounds on human lymphocytes and monocytes. I. Suppression of T-cell activation. Immunopharmacol Immunotoxicol 14:539-553.
4. Makani S, Gollapudi S, Yel L, Chiplunkar S, Gupta S. (2002) Biochemical and molecular basis of thimerosal-induced apoptosis in T cells: a major role of mitochondrial pathway. Genes Immun 3:270-278. (Pubitemid 38967552)
5. Goldman LR, Shannon MW; American Academy of Pediatrics: Committee on Environmental Health. (2001) Technical report: mercury in the environment: implications for pediatricians. Pediatrics 108:197-205. (Pubitemid 32592029)
6. Halsey NA. (1999) Limiting infant exposure to thimerosal in vaccines and other sources of mercury. JAMA 282:1763-1766. (Pubitemid 29533608)
7. Pichichero ME, Cernichiari E, Lopreiato J, Treanor J. (2002) Mercury concentrations and metabolism in infants receiving vaccines containing thiomersal: a descriptive study. Lancet 360:1737-1741. (Pubitemid 35447903)
8. Thimerosal in vaccines - An interim report to clinicians. American Academy of Pediatrics. (1999) Committee on Infectious Diseases and Committee on Environmental Health. Pediatrics 104:570-574.
9. Axton JH. (1972) Six cases of poisoning after a parenteral organic mercurial compound (Merthiolate). Postgrad Med J 48:417-421.
10. Fagan DG, Pritchard JS, Clarkson TW, Greenwood MR. (1977) Organ mercury levels in infants with omphaloceles treated with organic mercurial antiseptic. Arch Dis Child 52:962-964. (Pubitemid 8266750)
11. Matheson DS, Clarkson TW, Gelfand EW. (1980) Mercury toxicity (acrodynia) induced by long-term injection of gammaglobulin. J Pediatr 97:153-155. (Pubitemid 10033789)
12. Pelassy C, Breittmayer JP, Ticchioni M, Aussel C. (1994) Effect of thimerosal on cytosolic calcium and phosphatidylserine synthesis in Jurkat T cells. Int J Biochem 26:93-96.
13. Lowell JA, Burgess S, Shenoy S, Curci JA, Peters M, Howard TK. (1996) Mercury poisoning associated with high-dose hepatitis-B immune globulin administration after liver transplantation for chronic hepatitis B. Liver Transpl Surg 2:475-478. (Pubitemid 26386869)
14. Pfab R, Mückter H, Roider G, Zilker T. (1996) Clinical course of severe poisoning with thiomersal. J Toxicol Clin Toxicol 34:453-460.
15. Clarkson TW. (2002) The three modern faces of mercury. Environ Health Perspect 110:11-23. (Pubitemid 34163090)
16. Geier DA, Young HA, Geier MR. (2010) Thimerosal exposure & increasing trends of premature puberty in the vaccine safety datalink. Indian J Med Res 131:500-507.
17. Krantz A, Dorevitch S. (2004) Metal exposure and common chronic diseases: a guide for the clinician. Dis Mon 50:220-262. (Pubitemid 38748935)
18. Counter SA, Buchanan LH. (2004) Mercury exposure in children: a review. Toxicol Appl Pharmacol 198:209-230. (Pubitemid 38952835)
19. Ratcliffe HE, Swanson GM, Fischer LJ. (1996) Human exposure to mercury: a critical assessment of the evidence of adverse health effects. J Toxicol Environ Health 49:221-270. (Pubitemid 26363180)
20. Hornig M, Chian D, Lipkin WI. (2004) Neurotoxic effects of postnatal thimerosal are mouse strain dependent. Mol Psychiatry 9:833-845. (Pubitemid 39273533)
21. James SJ, Slikker W 3rd, Melnyk S, New E, Pogribna M, Jernigan S. (2005) Thimerosal neurotoxicity is associated with glutathione depletion: protection with glutathione precursors. Neurotoxicology 26:1-8. (Pubitemid 39440960)
22. Colombo M, Hamelin C, Kouassi E, Fournier M, Bernier J. (2004) Differential effects of mercury, lead, and cadmium on IL-2 production by Jurkat T cells. Clin Immunol 111:311-322. (Pubitemid 38739325)
23. Woo KJ, Lee TJ, Bae JH, Jang BC, Song DK, Cho JW, et al. Thimerosal induces apoptosis and G2/M phase arrest in human leukemia cells. Mol Carcinog 45:657-666.
24. Bahia Mde O, De Amorim MI, Burbano RR, Vincent S, Dubeau H. (1999) Genotoxic effects of mercury on in vitro cultures of human cells. An Acad Bras Cienc 71:437-443.
25. Ogura H, Takeuchi T, Morimoto K. (1996) A comparison of the 8-hydroxydeoxyguanosine, chromosome aberrations and micronucleus techniques for the assessment of the genotoxicity of mercury compounds in human blood lymphocytes. Mutat Res 340:175-182. (Pubitemid 126657375)
26. Cedrola S, Guzzi G, Ferrari D, Gritti A, Vescovi AL, Pendergrass JC, et al. Inorganic mercury changes the fate of murine CNS stem cells. FASEB J 17:869-871.